— Know what they know.
Not Investment Advice

VREOF OTC

Vireo Growth Inc.
1W: -15.7% 1M: -12.1% 3M: -2.7% YTD: +1475.1%
$9.49
-0.36 (-3.65%)
 
Weekly Expected Move ±12.6%
$7 $8 $9 $11 $12
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 29 · $363.0M mcap · 19M float · 0.253% daily turnover · Short 21% of daily vol

Balance Sheet Trends

Total Assets
$817M +193.0% ▲
5Y CAGR: +835.1%
Total Liabilities
$510M +128.3% ▲
5Y CAGR: +396.5%
Shareholders Equity
$307M +453.3% ▲
Cash & Investments
$103M +12.7% ▲
5Y CAGR: +765.6%
Total Debt
$304M +237.1% ▲
Net Debt
$201M +13441.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2025
— Assets —
Cash$228K$132K$8M$26M$102M
Short-Term Investments$0$0$0$0$1M
Cash & ST Investments$228K$132K$8M$26M$103M
Net Receivables$11K$14K$1M$697K$116M
Inventory$0$0$32M$13M$60M
Other Current Assets$0$0$10M$8M$22M
Total Current Assets$239K$146K$51M$47M$305M
Property, Plant & Equip.$2K$1K$39M$31M$271M
Goodwill & Intangibles$0$0$12M$12M$205M
Long-Term Investments$0$0$0$0$6M
Other Non-Current Assets$0$0$3M$0$30M
Total Non-Current Assets$2K$1K$54M$42M$512M
Total Assets$241K$147K$105M$89M$817M
— Liabilities —
Accounts Payable$15K$12K$3M$13M$19M
Short-Term Debt$0$0$0$0$18M
Deferred Revenue$0$0$0$0$5M
Other Current Liabilities$3K$0$620K$6M$120M
Total Current Liabilities$18K$12K$4M$20M$192M
Long-Term Debt$0$0$2M$1M$136M
Other Non-Current Liab.$0$0$29M$0$25M
Total Non-Current Liabilities$0$0$35M$1M$318M
Total Liabilities$18K$12K$39M$40M$510M
— Equity —
Common Stock$12M$11M$118M$0$0
Retained Earnings-$13M-$12M-$60M$0-$300M
Accumulated OCI-$2K-$2K-$2M$0$0
Total Stockholders Equity$223K$135K$66M$62M$307M
Total Liabilities & Equity$241K$147K$105M$89M$817M
— Key Metrics —
Total Debt$0$0$31M$1M$304M
Net Debt-$228K-$132K$24M-$24M$201M
Total Investments$0$0$0$0$7M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms